Company Media

Create Fukang · lead new industry standard: type III collagen dressing successfully launched

2019-04-28

At 13:30 p.m. on April 27, 2019, leading figures in the field and industry gathered together to witness the launch of chuangfukang type III collagen patch dressing. At present, there are only a few medical repair dressings among the approved class III medical devices in China.

At the same time, the listing society, together with Yang rongya, member of the Standing Committee of medical cosmetology and Cosmetology credit association of Chinese Medical Association, Professor Zhang Jianzhong, Chinese director of international dermatology Alliance (lids), and hundreds of dermatologists from all over the country, gathered in Zhuhai International Convention and Exhibition Center to give a brief introduction and in-depth discussion to the guests from the aspects of research and development and clinical practice.


创福康·引领行业新(xīn)标准:Ⅲ类胶原贴敷料成功上市 

创福康Ⅲ类胶原贴敷料上市启动仪式

 

Chuangfukang type III collagen dressing

According to the data of new oxygen app, in 2018, the market scale of China's medical and American medicine may reach 224.5 billion yuan, with a year-on-year growth rate of 27.57%. In the past three years, the average annual growth rate of China's medical and American market has reached 31.83%, which is in the outbreak period, and has become the fastest developing country in this field in the world. At present, there are many products in the field of medical cosmetology. Many cosmetics and class I and II medical devices claim to be medical and aesthetic products. However, due to the inconsistent regulatory requirements and strength of each place, the standards of products are different, and the good and bad are different. Based on this situation, chuang'erbio began to upgrade the management category of products in 2013 to guide the industry to achieve high standards and strict requirements for such products.

Chuangfukang type III collagen dressing, as a highly effective skin repair product independently developed by chuang'er biology and Guangdong medical collagen engineering technology research and development center, has attracted the attention of dermatologists since the date of research and development. Since the registration certificate was successfully obtained in 2016, in just two years, class III collagen dressing combined with a variety of therapies or drugs to treat problematic skin, such as acne, dermatitis and eczema, has attracted much attention in the clinical field. Chuang'er biology has always been committed to the innovative research and development of active collagen. In the future, chuang'er biology advocates cooperation and joint treatment of more disciplines, and the therapeutic effect on various types of skin problems will be better and better.

Create Fukang type III collagen dressing and lead the new standard of collagen patch industry

On April 27, 2019, as one of the few mechanical collagen patch dressings with class III Registration Certificate in China, chuangfukang, together with Yang rongya, Professor Zhang Jianzhong and hundreds of dermatologists from all over the country, gathered in Zhuhai International Convention and Exhibition Center to jointly launch the listing ceremony of chuangfukang type III collagen patch dressing. In the past 15 years, chuangfukang has been focusing on the research and development of active collagen. Chuangfukang has combined the patent technology of active collagen with the innovation of dermatology treatment. As one of the few skin repair dressings in the industry that has obtained the registration certificate of class III medical devices and put into the market, it has provided more effective repair products for skin clinical treatment, and has always had physical strength to solve the skin problems of many patients Experts, dermatologists of major hospitals and professionals widely recognized and highly praised.

At the press conference, Ms. Lei Jing, the R & D director of chuang'er biology, said: "Chuang Fukang collagen patch dressing was jointly hatched by chuang'er biological research and development team and Guangzhou Red Cross trauma research institute. With natural active collagen as the core material, it can effectively repair the damaged skin barrier. It has been widely used in dermatology and burn department for many years, and is well recognized by the majority of users. Chuang'er biological has not stopped pursuing high quality and high standards. Through continuous exploration, chuangfukang type III collagen patch dressing was successfully registered in 2016. It not only adheres to the advantages of type II collagen patch with high activity, high purity and good biocompatibility, but also greatly improves the content and concentration of collagen on the original basis, and adopts aseptic production, which can be said to be the current situation One of the products of the same kind produced to the highest standards in the industry. "


创福康·引领行业新(xīn)标准:Ⅲ类胶原贴敷料成功上市

会议上,雷静总监对Ⅲ类胶原贴进行产品介绍


Professor Zhang Jianzhong, chief physician of Dermatology Department of people's Hospital of Peking University, chairman of Dermatology and Venereology branch of Chinese Medical Association, director of Dermatology and Venereology Department of Peking University and China Council of international dermatology Alliance (lids), pointed out that the national approval of class III medical devices is very strict The leader in collagen industry is also the initiator of collagen dressing and medical collagen standard. He can actively improve the supervision category of products and make high standard and high quality products. It is a responsibility for patients, which is worthy of affirmation and trust. Now Chuang Fukang has been upgraded to class III medical devices, which is a new standard and a new height.

创福康·引领行业新(xīn)标准:Ⅲ类胶原贴敷料成功上市

上市会现场座无虚席

 

He is vice chairman of Pan Asian Society of facial plastic and reconstructive surgery and chairman of laser and minimally invasive anti-aging Special Committee; vice president, executive director and vice president of minimally invasive and skin plastic branch of China plastic and Cosmetic Association; chairman of Dermatology Committee of the whole army; standing member of Dermatology and Venereology branch of Chinese Medical Association and leader of laser cosmetology group; and medical cosmetology and cosmetology of Chinese Medical Association Professor Yang rongya, member of the Standing Committee of the Chinese society of dermatologists, said at the meeting that "for our dermatologists, we can not control the production standards and technologies of a product, and we will rely more on the state's supervision of drugs and devices. As the highest level medical devices in China, class III medical devices have the most stringent regulatory level and production requirements compared with class I and II. Therefore, we are more reliable and willing to accept high regulatory level medical devices such as class III collagen dressing ". At the same time, she also shared her experience in clinical application of chuangfukang class III collagen dressing.

图片4.png

杨蓉娅教授在会议上发表讲话

 

Chuangfukang is a pioneer in the collagen patch industry in China. It is a professional skin repair product. It has been committed to the research of bioactive collagen on "repairing skin barrier". Today. There are nearly 2000 hospitals and tens of thousands of dermatologists in China choose chuangfukang as medical repair products. Compared with the common medical mask, collagen III dressing is safer and more reliable, and more reliable.

From obscurity to great concern, Fukang has become a trusted brand in the industry with its high standards, strict standards and the attitude of keeping improving. So far, there are more than 160 domestic literatures about chuangfukang in the adjuvant treatment of various skin diseases. Such recognition is extremely rare in the medical repair dressing product industry. It is believed that chuangfukang will make continuous progress and reach new heights in the future. It will lead the collagen paste industry to new standards and bring more gospel to patients with skin problems.